UNIVERSITY COLLEGE DUBLIN VOLUNTEERS OVERSEAS

Irish Consortium Secures €2 Million to Reduce Gene Therapy Manufacturing Costs

- A strategic partnership between APC, NIBRT, and UCD has received €2 million in funding from Research Ireland and APC to develop more efficient gene therapy manufacturing processes. - The Trans-Am project aims to address the high manufacturing costs of gene therapies, which can cost millions of euros per dose, by improving production methods and analytical techniques. - Researchers will focus on overcoming cellular defense mechanisms against virus production and developing new cell lines to enhance manufacturing efficiency. - The five-year initiative seeks to strengthen Ireland's position in the global biopharmaceutical industry and increase patient access to revolutionary gene therapies.